RMD · News · 20260807N

Free Cash Flow

RESMED INC · 2026-08-07 · Importance 43 · Surprise 6 · In source text

ResMed generated approximately $1.6 billion of free cash flow during fiscal 2026. Strong free cash flow supported $1.0 billion of shareholder returns through repurchases and dividends. The company expects to allocate more than $1.85 billion to dividends and share repurchases in fiscal 2027. The reported cash generation remained robust despite Astral safety-action expenses.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
cashpositiverealizedResMed generated $1.6 billion in free cash flow for the full fiscal year.